Absci to participate in upcoming investor conferences

Vancouver, wash., feb. 17, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences.
ABSI Ratings Summary
ABSI Quant Ranking